{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:34:02Z","timestamp":1793050442978,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.09.116","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:32Z","timestamp":1791389552000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adoption of the Fifth Workshop Urinary Calcium Threshold in Asymptomatic Primary Hyperparathyroidism"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6622-4267","authenticated-orcid":false,"given":"Elena","family":"Castellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Boriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2026.09.116_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.eprac.2026.09.116_bib2","article-title":"Epidemiology, pathophysiology and genetics of primary hyperparathyroidism","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.116_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2008-1761","article-title":"Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Udelsman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.116_bib4","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2026.09.116_bib5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.eprac.2026.09.116_bib6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1210\/js.2019-00316","article-title":"Clinical presentation of primary hyperparathyroidism in older adults","volume":"3","author":"Castellano","year":"2019","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.116_bib7","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.116_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/ijerph13060544","article-title":"BMI and BMD: the potential interplay between obesity and bone fragility","volume":"13","author":"Palermo","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eprac.2026.09.116_bib9","first-page":"1027","article-title":"Obesity as a protective factor for postmenopausal osteoporosis","volume":"20","author":"Albala","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.eprac.2026.09.116_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0026-0495(93)90241-F","article-title":"The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women","volume":"42","author":"Haffner","year":"1993","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.eprac.2026.09.116_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198002213020801","article-title":"The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism","volume":"302","author":"Broadus","year":"1980","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.116_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/metabo15100639","article-title":"Vitamin D metabolism and the risk of renal stones: a focus on PHPT","volume":"15","author":"Castellano","year":"2025","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.116_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40618-019-01162-y","article-title":"Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?","volume":"43","author":"Saponaro","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.116_bib14","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.116_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF03346915","article-title":"Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women","volume":"20","author":"Ongphiphadhanakul","year":"1997","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.eprac.2026.09.116_bib16","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1210\/jc.2017-01080","article-title":"Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status","volume":"102","author":"Castellano","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.09.116_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1671905","article-title":"The predictive value of 24-hour urinary calcium for kidney stone risk in primary hyperparathyroidism: insight from a retrospective study of parathyroid adenoma cases","volume":"16","author":"Bhan","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2026.09.116_bib18","first-page":"186","article-title":"Micro-costing analysis from Italian guidelines for the management of sporadic primary hyperparathyroidism","volume":"12","author":"Valentini","year":"2025","journal-title":"Glob Reg Health Technol Assess"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.116_bib19","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.116_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0090-4295(99)00617-2","article-title":"Impact of body weight on urinary electrolytes in urinary stone formers","volume":"55","author":"Powell","year":"2000","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.eprac.2026.09.116_bib21","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1210\/jc.2013-3903","article-title":"The impact of obesity on the presentation of primary hyperparathyroidism","volume":"99","author":"Tran","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.116_bib22","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","article-title":"Thiazide treatment in primary Hyperparathyroidism-A new indication for an old medication?","volume":"102","author":"Tsvetov","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:02Z","timestamp":1793047142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26012632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S1530891X26012632"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.116","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adoption of the Fifth Workshop Urinary Calcium Threshold in Asymptomatic Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}